Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors

Overview of attention for article published in Frontiers in oncology, February 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 22 X posts from 15 X users, with an upper bound of 130,403 followers.

@JackWestMD @HosseinBorghaei @CharuAggarwalMD @slcphd @StephenVLiu @benlevylungdoc @MLJohnsonMD2 @GlopesMd @dave6408 Assay is an issue as much as the way mutations are counted. Clearly quality and not quantity.Many including us @DralexGva have worked on th

RT @Alfdoc2: Huge team effort. @DralexGva @gbanna74

Huge team effort. @DralexGva @gbanna74

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.